A detailed analysis of more than 60 randomized controlled trials published in the Journal of American Medical Association reveals that there is no evidence of a significantly increased risk of any type of cancer due to the use of biologic response modifiers (BRMs) in treating rheumatoid arthritis. "Rheumatoid arthritis (RA) is a systemic inflammatory polyarthritis that can lead to significant morbidity, joint deformity, and impaired quality of life and affects approximately ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment